bioAffinity Technologies, Inc. (BIAFW) Financial Forecast
United States · Industrial & Consumer Products · USD · Annual
Key financials
USD
ROE
-301.83%
2025 (actual)
ROA
-170.65%
2025 (actual)
Gross Margin
100%
2025 (actual)
Net Margin
-241.96%
2025 (actual)
Total Assets
$10,960,772.00
2025 (actual)
Net Income
-$14,909,754.00
2025 (actual)
Valuation
-
Stock Price
-
Historical & projected performance
USD
Reported figures and Equlion model projections for the next 5 years.
ROE
+329.8 pt
Company
Sector average (own scale)
ROA
-111.5 pt
Company
Gross Margin
+0 pt
Company
Sector average
Net Margin
-12.4 pt
Company
Total Assets
-22.3%
Company
Net Income
-58.1%
Company
Detailed data
USD
Amounts in USD; stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Projections are model estimates, not investment advice.
Want the full financial forecast report for bioAffinity Technologies, Inc.? It covers the balance sheet, income statement, cash flow and Equlion model projections.